TrialAnnals of the rheumatic diseases2016

Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.

Valérie Devauchelle-Pensec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.